The combination of peritumoral FlaB-Vax delivery with PDT effectively induced a systemic and local response of peptide tumor antigen-specific IFNγ-secretions and accumulation of effector memory CD8+ T cells, which further enhanced PD-1 blockade therapeutic outcome. The gene discussed is CD8A; the disease is neoplasm.